«KabiGen AB

Below is an extended KabiGen AB news listing. Click here to return to the KabiGen AB main Biocorporate entry.

BioNews Results for KabiGen AB:
::: Circadian Technologies Preliminary Final Report (Appendix 4E) (Audited) Financial Year Ended 30 June 2008 Biotech Intelligence: Aug 24 2008 6:36PM Matching: ab
Real estate transactions for Aug. 17, 2008 Press of Atlantic City: Aug 24 2008 10:15AM Matching: ab
::: Qiagen launches Olerup SSP AB's new test for detecting adverse reactions to HIV-medicine in the EU Biotech Intelligence: Aug 23 2008 2:18AM Matching: ab
Entecavir Therapy for Adefovir-Resistant Hepatitis B Virus Infection in Kidney and Liver Allograft Recipients Transplantation: Aug 23 2008 9:49AM Matching: ab
Form 3 ACHILLION PHARMACEUTICAL For: Aug 12 Filed by: INVESTOR AB Street Insider: Aug 22 2008 10:47PM Matching: ab
PON1 phenotype may predict statin efficacy MedWire News: Aug 22 2008 9:29PM Matching: ab
LinkMed: Qiagen launches Olerup SSP AB's new test for detecting adverse reactions to HIV-medicine in the EU Yahoo! Canada: Aug 22 2008 9:28AM Matching: ab
APEI Announces Limited Distribution of APEI Shares by ABS Capital Partners Genetic Engineering News: Aug 22 2008 1:18AM Matching: ab
A Systematic Review With Procedural Assessments and Meta-analysis of Low Level Laser Therapy in Lateral Elbow Medscape: Aug 22 2008 9:18PM Matching: ab
Eczema Herpeticum: A Manifestation of Hyperimmunoglobulin E Syndrome Consultant Live: Aug 22 2008 9:36AM Matching: ab
Spectroscopic and Molecular Dynamics Evidence for a Sequential Mechanism for the A-to-B Transition in DNA Red Orbit: Aug 22 2008 9:01AM Matching: ab
Studies conducted at S.M. Alavian et al on hepatitis B virus recently published Calibre Macro World: Aug 21 2008 10:23PM Matching: ab
Swedish biotech company BioGaia AB posts 1H operating profit of SEK12.6m M2: Aug 21 2008 12:22PM Matching: ab
Swedish biotech company BioGaia AB signs licence agreement with Nestle M2: Aug 21 2008 12:21PM Matching: ab
Business briefs: Star-Telegram offering employee buyouts Star-Telegram: Aug 21 2008 10:40AM Matching: ab

«KabiGen AB

This page contained an extended KabiGen AB news listing. Click here to return to the KabiGen AB main Biocorporate entry.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.